NASDAQ: SBFM
Sunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?

Insider buying vs selling

Have Sunshine Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SBFM insiders and whales buy or sell their stock.

SBFM Shareholders

What type of owners hold Sunshine Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Malek Chamoun95.43%3,700,000$3.11MInsider
Camille Sebaaly4.50%174,465$146.73kInsider
Steve N. Slilaty3.35%130,000$109.33kInsider
David Natan1.76%68,300$57.44kInsider
Janstr0.00%15$12.62Institution
Jane Street Group LLC0.00%15$12.62Institution
Michel Roy0.00%1$0.84Insider
Caitong International Asset Management Co Ltd0.00%0$0.00Institution
Canada0.00%0$0.00Institution
Farthe0.00%0$0.00Institution

1 of 3

SBFM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SBFM0.00%100.00%
PRFX0.01%0.00%
UPC0.01%2.85%
APUS0.01%99.99%
AKAN0.00%2.00%Net Selling

Sunshine Biopharma Stock Ownership FAQ

Who owns Sunshine Biopharma?

Sunshine Biopharma (NASDAQ: SBFM) is owned by 0.00% institutional shareholders, 105.04% Sunshine Biopharma insiders, and 0.00% retail investors. Malek Chamoun is the largest individual Sunshine Biopharma shareholder, owning 3.70M shares representing 95.43% of the company. Malek Chamoun's Sunshine Biopharma shares are currently valued at $3.33M.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.